CORC

浏览/检索结果: 共5条,第1-5条 帮助

限定条件                    
已选(0)清除 条数/页:   排序方式:
RECORD-4: A multicenter, phase II trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC) 会议论文
作者:  Motzer, Robert;  Alyasova, Anna;  Ye, Dingwei;  Karpenko, Andrey;  Li, Hanzhong
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/19
Abiraterone acetate after docetaxel-based chemotherapy failure in Asian patients with metastatic castration-resistant prostate cancer 会议论文
作者:  Ye, Dingwei;  Zou, Qing;  Sun, Zhongquan;  Sun, Yinghao;  Li, Changling
收藏  |  浏览/下载:11/0  |  提交时间:2019/12/19
Age-Specific Cutoff Value for the Application of Percent Free Prostate-Specific Antigen (PSA) in Chinese Men with Serum PSA Levels of 4.0-10.0 ng/ml 期刊论文
PLOS ONE, 2015, 卷号: 10, 期号: 6
作者:  Chen, Rui;  Huang, Yiran;  Cai, Xiaobing;  Xie, Liping;  He, Dalin
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/19
RECORD-4: a multicenter phase 2 trial of second-line everolimus (EVE) in patients with metastatic renal cell carcinoma (mRCC) 会议论文
作者:  Cosgriff, Thomas;  Alyasova, Anna;  Ye, Dingwei;  Xie, Liping;  Kurteva, Galina
收藏  |  浏览/下载:1/0  |  提交时间:2019/12/19
Percent free prostate-specific antigen for prostate cancer diagnosis in Chinese men with a PSA of 4.0-10.0 ng/mL: Results from the Chinese Prostate Cancer Consortium 期刊论文
ASIAN JOURNAL OF UROLOGY, 2015, 卷号: 2, 期号: 2
作者:  Chen, Rui;  Xie, Liping;  Cai, Xiaobing;  Huang, Yiran;  Zhou, Liqun
收藏  |  浏览/下载:14/0  |  提交时间:2019/12/19


©版权所有 ©2017 CSpace - Powered by CSpace